News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Peter Wirth Named Chairman of the FORMA Therapeutics, Inc. Board of Directors


11/13/2012 9:41:52 AM

WATERTOWN, Mass.--(BUSINESS WIRE)--FORMA Therapeutics today announced the appointment of Peter Wirth, former Executive Vice President, Legal and Corporate Development, Chief Risk Officer and Corporate Secretary of Genzyme, as Chairman of the Board of Directors. Mr. Wirth will replace Alexis Borisy of Third Rock Ventures who is stepping down from the Board.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES